Douglas & London, P.C., in collaboration with other members of the AFFF MDL Plaintiffs’ Executive Committee, published allocation estimates yesterday that detail funding that will be made available to public water systems as part of the combined $13.6 billion settlement from litigation against PFAS manufacturers 3M and DuPont.
‘Forever Chemical’ Lawsuits Could Ultimately Eclipse the Big Tobacco Settlement. Thousands of lawsuits remain pending around the country—a number that could grow to millions.
Attorneys representing public water systems on Thursday announced that a $12.5 billion deal has been reached with 3M to end claims over contamination from so-called forever chemicals in firefighting foam, in what they say is the largest settlement over drinking water in U.S. history.
The deal followed an agreement by Chemours, DuPont and Corteva to pay $1.19 billion to help resolve claims that the chemical manufacturers contaminated drinking water across the country.
Manufacturing giant 3M has agreed to pay $10.3 billion over 13 years to close to 300 cities and counties where potentially harmful compounds were found in water supplies. NBC News’ Maggie Vespa has the details on the class-action settlement, which is one of the largest in U.S. history.
Katie Couric talks to lead trial counsel Gary Douglas about the historic Multi-Billion Dollar Settlement with 3M Company over PFAS Contamination and how another trial involving people who got cancer and other diseases from exposure to these chemicals is next.
Douglas & London, P.C. is proud to announce that 3M has agreed to pay up to twelve billion five hundred million dollars ($12,500,000,000) to public water systems across the United States that have detected or are at risk for PFAS chemicals in their drinking water, in what is the largest drinking water settlement in American history.
It’s about time! Congratulations to the well deserved women in the Ethicon Inc’s (a unit of Johnson & Johnson)Power Morcellator MDL. Our firm just represented one of these clients in the medical malpractice suit in NY, in which the client died. Bravo to U.S. District Judge Kathy Vratil of Kansas for speaking loudly about “best practices” in MDL’s.
Lawyers from Seeger Weiss and Douglas & London have been selected as co-lead counsel for plaintiffs who allege Johnson & Johnson’s Type II diabetes drug Invokana can cause kidney damage.
In an order on Tuesday, U.S. District Judge Brian Martinotti in Trenton, New Jersey, appointed Christopher Seeger and Michael London to serve as co-lead counsel in multidistrict Invokana litigation. Martinotti also named liaison counsel, a three-member executive committee and a eight-member steering committee for the MDL.
NEW YORK, Aug. 22, 2018 /PRNewswire/ — Douglas & London, P.C. is proud to announce that three of our attorneys have been selected for inclusion in the 2019 Edition of The Best Lawyers in America©. This is the second straight year Michael London and Virginia Anello have been recognized by Best Lawyers© and Gary J. Douglas’ first year of recognition. All three attorneys are being recognized in the category of “Mass Tort Litigation / Class Actions – Plaintiffs.”
